At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
continuous glucose monitoring (CGM)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
iPro Continuous Glucose Monitor in Children With Poorly Controlled Diabetes: A 6-Month, Randomized, Interventional Pilot Study
The University of Texas Health Science Center at San Antonio·observational·Posted Aug 21, 2015·Updated Oct 6, 2017
In Brief
An observational study evaluating continuous glucose monitoring (CGM) for Type 1 Diabetes Mellitus. Completed, enrolled 30 participants.
Detailed Summary
The purpose of this study is to determine if the use of continuous glucose monitoring in a practical outpatient clinic setting in children with poorly controlled diabetes will lead to improved blood sugar control.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
Countries--
CollaboratorsMedtronic MiniMed, Inc.
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
Primary CompletionMar 2013
First PostedAug 2015
TodayJul 2026
First PostedAug 21, 2015
Enrollment StartMay 1, 2011
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.9 years ago
Interventions
continuous glucose monitoring (CGM)device
All subjects in Groups 1 and 2 wore the CGM device at time points 0, 3 months, and 6 months. Group 1 did not review CGM data at time 0, but did review CGM data at time point 3 months and 6 months. Group 2 reviewed CGM data at all time points.